1. NS6180, a new KCa3.1 channel inhibitor prevents T‐cell activation and inflammation in a rat model of inflammatory bowel disease. (20th December 2012) Authors: Strøbæk, D; Brown, DT; Jenkins, DP; Chen, Y‐J; Coleman, N; Ando, Y; Chiu, P; Jørgensen, S; Demnitz, J; Wulff, H; Christophersen, P Journal: British journal of pharmacology Issue: Volume 168:Number 2(2013:Jan.) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NS6180, a new KCa3.1 channel inhibitor prevents T‐cell activation and inflammation in a rat model of inflammatory bowel disease. (20th December 2012) Authors: Strøbæk, D; Brown, DT; Jenkins, DP; Chen, Y‐J; Coleman, N; Ando, Y; Chiu, P; Jørgensen, S; Demnitz, J; Wulff, H; Christophersen, P Journal: British journal of pharmacology Issue: Volume 168:Number 2(2013:Jan.) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗